New Cholesterol Guidelines: Screening, Risk, and Targets
Big changes in cholesterol guidelines will spark conversations about managing patients withOUT atherosclerotic cardiovascular disease (ASCVD).
Be ready to discuss earlier screening and treatment...LDL-C targets...and the role of CV risk markers (lipoprotein(a), etc).
Screening. Recommend a lipid profile (fasting or nonfasting) for patients between ages 9 and 11 years...and again at 19 years.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote